2.39 Effectiveness of Newer-Generation Antidepressants with Dr. Michael Hengartner
Our guest this week is Dr. Michael Hengartner of …
Plenary Session - inactive due to federal service · Plenary Session - inactive due to federal service
February 27, 202042m 40sExplicit
Audio is streamed directly from the publisher (feeds.soundcloud.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
Our guest this week is Dr. Michael Hengartner of the Zurich University of Applied Sciences. We interview him on his work studying the long-term consequences and effectiveness of newer-generation antidepressants - specifically focusing on selective serotonin reuptake inhibitors (SSRIs).
Back us on Patreon! www.patreon.com/plenarysession
Topics
medicineoncologyhealthpolicy